GETTING MY RAW MATERIALS TO WORK

“The present scenario has uncovered some structural weaknesses in the EU’s medicines provide chain along with a large dependence on non-EU international locations for active pharmaceutical ingredients,” Kyriakides claimed. She proposed that offer chain concerns be tackled within an EU pharmaceutical system envisioned to be launched by the end